Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Expert Opinion on Therapeutic Patents|November 14, 2015
COX inhibitors: a patent review (2011 - 2014)Sara Consalvi, Mariangela Biava, Giovanna PoceMini Reviews in Medicinal Chemistry|January 19, 2016
MmpL3 Inhibitors: Diverse Chemical Scaffolds Inhibit the Same TargetGiovanna Poce, Sara Consalvi, Mariangela BiavaEuropean Journal of Medicinal Chemistry|September 1, 2014
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical developmentGiovanna Poce, Martina Cocozza, Sara Consalvi, et al.Bioorganic & Medicinal Chemistry Letters|October 20, 2019
Mycobacterial tryptophan biosynthesis: A promising target for tuberculosis drug development?Sara Consalvi, Cristina Scarpecci, Mariangela Biava, et al.Pharmaceuticals (Basel, Switzerland)|September 4, 2020
SAR Analysis of Small Molecules Interfering with Energy-Metabolism in Mycobacterium tuberculosisFederico Appetecchia, Sara Consalvi, Cristina Scarpecci, et al.Expert Opinion on Therapeutic Patents|March 4, 2022
Malaria transmission blocking compounds: a patent reviewSara Consalvi, Chiara Tammaro, Federico Appetecchia, et al.Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent AdvancesChiara Tammaro, Michela Guida, Federico Appetecchia, et al.Pharmaceutics|June 27, 2024
Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug DiscoveryMichela Guida, Chiara Tammaro, Miriana Quaranta, et al.Antioxidants (Basel, Switzerland)|October 5, 2019
Chocolate Consumers and Lymphocyte-to-Monocyte Ratio: A Working Hypothesis from a Preliminary Report of a Pilot Study in Celiac SubjectsAnna Raguzzini, Giovanna Poce, Sara Consalvi, et al.Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug DevelopmentFederico Appetecchia, Emanuele Fabbrizi, Francesco Fiorentino, et al.Pageof 3